Toxic effects of dopamine metabolism in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 15, Issue 1, 2009, Pages

  Hattoria, Nobutaka ^a   Wanga, Mei ^a   Taka, Hikari ^a   Fujimura, Tsutomu ^a   Yoritaka, Asako ^a   Kubo, Shin ichiro ^a   Mochizuki, Hideki ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

4 Hydroxy nonenal; Levodopa; Mitochondrial dysfunctions; Oxidative stress; Parkinson's disease

Indexed keywords

ALDEHYDES; ALPHA-SYNUCLEIN; ANIMALS; DOPAMINE; HUMANS; LEVODOPA; MITOCHONDRIA; OXIDATIVE STRESS; PARKINSON DISEASE;

EID: 58149141576     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(09)70010-0     Document Type: Article

References (23)

1. Dexter D.T., Carter C.J., Wells F.R., Javoy-Agid F., Agid Y., Lees A., et al. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 2 (1989) 381-389
2. Sian J., Dexter D.T., Lees A.J., Daniel S., Agid Y., Javoy-Agid F., et al. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 36 (1994) 348-355
3. Dexter D.T., Carayon A., Vidailhet M., Ruberg M., Agid F., Agid Y., et al. Decreased ferritin levels in brain in Parkinson's disease. J Neurochem 55 (1990) 16-20
4. Shastry B.S. Neurodegenerative disorders of protein aggregation. Neurochem Int 43 (2003) 1-7
5. Fahn S., Oakes D., Shoulson I., Kieburtz K., Rudolph A., Lang A., et al. Levodopa and the progression of Parkinson's disease. N Engl J Med 351 (2004) 2498-2508
6. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., and Goedert M. Alpha-synuclein in Lewy bodies. Nature 388 (1997) 839-840
7. Maroteaux L., Campanelli J.T., and Scheller R.H. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 8 (1988) 2804-2815
8. Uversky V.N., Gillespie J.R., and Fink A.L. Why are "natively unfolded" proteins unstructured under physiologic conditions?. Proteins 41 (2000) 415-427
9. Weinreb P.H., Zhen W., Poon A.W., Conway K.A., and Lansbury Jr. P.T. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35 (1996) 13709-13715
10. Kubo S., Nemani V.M., Chalkley R.J., Anthony M.D., Hattori N., Mizuno Y., et al. A combinatorial code for the interaction of alpha-synuclein with membranes. J Biol Chem 280 (2005) 31664-31672
11. Zhu M., Li J., and Fink A.L. The association of alpha-synuclein with membranes affects bilayer structure, stability, and fibril formation. J Biol Chem 278 (2003) 40186-40197
12. Davidson W.S., Jonas A., Clayton D.F., and George J.M. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem 273 (1998) 9443-9449
13. Qin Z., Hu D., Han S., Reaney S.H., Di Monte D.A., and Fink A.L. Effect of 4-hydroxy-2-nonenal modification on alpha-synuclein aggregation. J Biol Chem 282 (2007) 5862-5870
14. Trostchansky A., Lind S., Hodara R., Oe T., Blair I.A., Ischiropoulos H., et al. Interaction with phospholipids modulates alpha-synuclein nitration and lipid-protein adduct formation. Biochem J 393 (2006) 343-349
15. Emdadul Haque M., Asanuma M., Higashi Y., Miyazaki I., Tanaka K., and Ogawa N. Apoptosis-inducing neurotoxicity of dopamine and its metabolites via reactive quinone generation in neuroblastoma cells. Biochim Biophys Acta 1619 (2003) 39-52
16. Hastings T.G., Lewis D.A., and Zigmond M.J. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc Natl Acad Sci USA 93 (1996) 1956-1961
17. Jones D.C., Gunasekar P.G., Borowitz J.L., and Isom G.E. Dopamine-induced apoptosis is mediated by oxidative stress and Is enhanced by cyanide in differentiated PC12 cells. J Neurochem 74 (2000) 2296-2304
18. Ikeuchi T., Kakita A., Shiga A., Kasuga K., Kaneko H., Tan C.F., et al. Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia. Arch Neurol 65 (2008) 514-519
19. Ahn T.B., Kim S.Y., Kim J.Y., Park S.S., Lee D.S., Min H.J., et al. Alpha-Synuclein gene duplication is present in sporadic Parkinson disease. Neurology 70 (2008) 43-49
20. Chartier-Harlin M.C., Kachergus J., Roumier C., Mouroux V., Douay X., Lincoln S., et al. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 364 (2004) 1167-1169
21. Pals P., Lincoln S., Manning J., Heckman M., Skipper L., Hulihan M., et al. Alpha-synuclein promoter confers susceptibility to Parkinson's disease. Ann Neurol 56 (2004) 591-595
22. Nishioka K., Hayashi S., Farrer M.J., Singleton A.B., Yoshino H., Imai H., et al. Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease. Ann Neurol 59 (2006) 298-309
23. Singleton A.B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., et al. Alpha-synuclein locus triplication causes Parkinson's disease. Science 302 (2003) 841